PLEXI-T
LIVE

Serial Number

98705565

Owner

TScan Therapeutics, Inc.

Attorney

Tiffany D. Gehrke

Filing Date

Aug 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PLEXI-T Trademark

Serial Number: 98705565

PLEXI-T is a trademark filed by TScan Therapeutics, Inc. on August 19, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

TScan Therapeutics, Inc. (8 trademarks)

Waltham, MA 02451

Entity Type: 03

Trademark Details

Filing Date

August 19, 2024

Registration Date

Not Registered

Published for Opposition

May 6, 2025

Goods & Services

Pharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer

Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 27, 2026 EXRA
SOU EXTENSION 2 GRANTED
May 26, 2026 EX2G
SOU EXTENSION 2 FILED
May 26, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
May 26, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 9, 2025 EXRA
SOU EXTENSION 1 GRANTED
Dec 8, 2025 EX1G
SOU EXTENSION 1 FILED
Dec 8, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 8, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 1, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 6, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 6, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 4, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2025 GNRN
NON-FINAL ACTION E-MAILED
Apr 1, 2025 GNRT
NON-FINAL ACTION WRITTEN
Apr 1, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 9, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2025 NWOS
NEW APPLICATION ENTERED
Aug 19, 2024 NWAP